In this ASCO Journal of Clinical Oncology special series on clinical trial eligibility, you can learn more about why more patients will be eligible for clinical trials. It’s also important to know if outcomes and side effects differ based on a participant’s sex, race or age group. The FDA’s Drug Trials Snapshots allows you to see who took part in the clinical trials that led to a drug’s approval and what, if any, differences were seen. And Cancer Today, pulls it all together in this feature on efforts to increase the number and type of participants in clinical trials.
Inside Clinical Trials
July 2018Reading this article from Breastcancer.org along with the FDA’s press release and a viewpoint by cancer writer Elaine Schattner, provides three perspectives...Read More
July 2018Below are MBC trials that have been added to Metastatic Trial Search in the last month. Triple Negative Gedatolisib plus PTK7-ADC for Metastatic Triple Negative...Read More
New To Clinical Trials?
The idea of finding and entering a clinical trial can seem daunting. Here’s a Clinical Trials Primer to get you started.
COVID-19 & Breast Cancer
Search Our Site
SEARCH OUR SITE
for past articles or specific information.